Welcome and good morning on our behalf as well. As usual, let's start with this quarter's highlights. We had stable order intake. The growth was 4% in total and 2% organically. Four out of five business areas experienced organic order intake growth. There was the strongest demand for companies in the process industry and in the energy sector. Net sales increased by 2% in total. Organically, it was flat compared to last year. EBITDA margin was stable and at a high level, 14.8%. We continued with inventory reductions in the quarter and we also had a strong cash flow. One acquisition was completed in Q3, one so far in Q4, and 13 in total for 2024. In total, 2024 saw 13 acquisitions and a continued strong pipeline. And I will elaborate more on all these points in the presentation here. So if we start with the order intake and the sales situation, as I said, order intake plus 4% and sales plus 2% in total. This was supported by a good acquisition pace, with acquisitions impacting both order intake and sales by plus 5%, while organic order intake grew by 2%. Sales were flat. We should also note that we had one more working day in the quarter versus Q3 last year. Book to bill was below one in the quarter, partly because of seasonal variations. We usually start the year in quarter one with a really good book to bill, and quarter three. It can be a little bit weaker, but the ratio this quarter was above last year's level. Four out of five business areas, and more than half of the companies, had positive organic order intake growth. But as usual, there were large variations between companies, segments, and countries, and companies with customers more broadly in the process industry. Industry and the energy sector experienced the strongest demand, while the business climate in the infrastructure and construction sectors, and also parts of the engineering customer segments, remained more subdued. And I will comment a bit more on all these points when we talk about the business areas. If we look at sales from a market country perspective, as it has been for a while, the strongest development was in the Nordics with the highest sales growth in Denmark. And as we have had it for some quarters, the growth in Denmark was mainly related to pharma production and deliveries to Novo Nordisk. Finland, on the other hand, exhibited slightly lower growth overall. We have also commented on this quite a lot, as it is a base industry CapEx-driven sort of business in Finland, and that's a bit weaker now. The decline in the UK and Ireland mainly relates to weaker sales within the construction segment in the UK. And we also had strong pharma customer references in Ireland. In central parts of Europe, the general business climate continues to be dampened. I would say Germany is the driver in terms of a weaker business situation there. Broadly, the automotive sector and sales to North America and Asia are slightly volatile, and the development can fluctuate with single projects, since these areas are relatively small for us. And this year, so far, more activities and projects have been noted primarily from US customers. In terms of profitability, EBITA margin was stable and high at 14.8%, but lower than the 15.2% we had the same period last year. Organic sales development, in combination with slightly higher expenses, is the main driver of the EBITA margin decline. The gross margin was slightly better than last year. If we exclude some one-off items, acquisitions and divestments were margin accretive. All in all, EBITDA decreased by a total of 1% compared to last year; organically, there was a decrease of 4%, but acquisitions and divestments had a positive effect of 6%. If we then turn to the business areas on an aggregated level, almost half of the company showed organic sales growth in the quarter. Business area. Life science had the strongest development, mainly driven by sales of diabetes-related products in the Nordics and, as previously mentioned, production equipment in Denmark. Stable and high sales for process energy and water, with good contributions from, for instance, the energy sector, but also the marine sector, again partly offset by a weaker market situation in Finland.
The slightly dampened market climate continues to impact the business areas of industrial and engineering, as well as infrastructure and construction. And if we talk about industrial and engineering, I would say it's broadly linked to the automotive sector and companies with direct and indirect business relationships to this sector. And this can, for example, be related to cutting tools or production equipment. It's primarily challenging in Germany, I would say, and in other countries around Germany. Offsetting positively, the automotive aftermarket develops well for those companies involved in that sector. And if we take infrastructure and construction, I would say sequentially rather flat. And it's not deteriorating; rather, we are expecting positive improvements at some point next year. And this is obviously linked to expected lower interest rates and a more positive investment climate in that area. The organic sales development in technology and system solutions is mainly explained by strong performances in a few companies. During Q3 last year, some companies had exceptionally high sales growth, for example, in the marine segment, driven by regulatory requirements for shipping vessels, as well as strong growth in leak detection for hydrogen tanks. As mentioned earlier, the organic sales development and slightly higher expenses were the main drivers of the EBITDA margin decline. The gross margin continued at a good level, and the margin in industrial engineering and process, energy, and water was essentially in line with the same period last year. Infrastructure and construction had positive contributions from acquisitions and divestments, which supported their margin improvement. And the margin in life sciences was record high in Q3 last year, presenting a challenging reference for this year, driven, for instance, by strong sales in the single-use area. This year we had a less favorable product mix in sales and also some one-offs impacting the results. The margin decline in the business area of technology and system solutions was mainly connected to lower sales, in combination with a slightly increased expense level. In general, companies are addressing their cost situations, driven by entrepreneurial opportunities and are hesitant to reduce costs too quickly if they anticipate that their activity levels will generate growth in the medium term. And, it's generally difficult to find really good people. So, I would say there's a logical hesitation to lay off people because of that. But there are absolutely some companies working with cost reductions. Uh, and this will have an effect already in Q4. If we then look at acquisitions, the pace has generally been high so far in 2024. We have been able to acquire 13 well-managed companies, and the combined annual sales account for a bit more than 1.2 billion SEK. If we look at this geographically, 60% are Nordic companies and 40% are outside the Nordics. In Q4, we have welcomed one company so far, but I would say that the pipeline is still very strong, and we have a number of projects in different phases ongoing. So you can expect that we will be able to conclude some further acquisitions already this year and hopefully have a good start to 2025. When we look at our acquisition track record. We usually say that it's good to have a longer time period perspective on this. And as I said, so far in 2024, good contributions in Q1, Q2, and Q3 following a weaker Q1. And regarding the financial effects, the bridge effects from acquisitions over the last 12 months have added close to 60 million SEK to the group's EBITA in the quarter, corresponding to an EBITA margin of around 16%. And by that, I leave the word over to you, Patrik, to comment more on the financials.